.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Express Scripts
Harvard Business School
Fuji
Chinese Patent Office
Federal Trade Commission
US Army
Merck
Cipla
Johnson and Johnson

Generated: November 19, 2017

DrugPatentWatch Database Preview

ORUDIS Drug Profile

« Back to Dashboard

What is the patent landscape for Orudis, and what generic Orudis alternatives are available?

Orudis is a drug marketed by Wyeth Ayerst and Wyeth Cons and is included in two NDAs.

The generic ingredient in ORUDIS is ketoprofen. There are twenty-seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-001Jul 31, 1987DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth Cons
ORUDIS KT
ketoprofen
TABLET;ORAL020429-001Oct 6, 1995DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-002Jan 9, 1986DISCNYesNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-003Jan 9, 1986DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ORUDIS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-001Jul 31, 1987► Subscribe► Subscribe
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-003Jan 9, 1986► Subscribe► Subscribe
Wyeth Ayerst
ORUDIS
ketoprofen
CAPSULE;ORAL018754-002Jan 9, 1986► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
UBS
Federal Trade Commission
Dow
Chinese Patent Office
Boehringer Ingelheim
Baxter
Colorcon
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot